ATOS

General Discussion
#1

I remember this was one Jim had tweeted about. SI % of FF 21.7% Any thoughts?

#2

It keeps getting shorted hard after good news. They should be at $8-12 off their results and financials. I think another pharmaceutical company is behind it because their breast cancer drug is looking game changing and they want to bury them or buy it for cheap. Unfortunately they are still a while away from bringing their covid spray and breast cancer drug to market so i don’t see it stopping unless the reddit community gets behind it.

BAM Investor is not a licensed broker, broker-dealer, market maker, investment banker, investment advisor, analyst or underwriter. Our discussions, analysis and predictions are derived by our interpretation of our proprietary model’s readings, and should not be misconstrued as an investment recommendation or advice in any form. It should be clearly understood by anyone viewing this site or related materials that investing in the stock market carries with it inherent risks and uncertainties. The actual results of a stock or commodity or currency could differ materially from descriptions given. There is a risk for substantial losses trading securities and commodities. Material and commentary provided is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or sell any securities.

The information contained on this website and any subsequent reports or articles are based on analysis of qualitative, statistical, and financial data and should not be interpreted as recommendations based on a complete investment evaluation. The information is based on sources that BAMinvestor believes to be reliable, but no representation, express or implied, is made with respect to the accuracy, completeness, reliability, or timeliness. The information is subject to change without notice, and BAMinvestor does not accept responsibility to update it.

BAMinvestor does not accept responsibility or liability for any direct, indirect, special, consequential, or other losses or damages of any kind whatsoever arising out of access to, or use of, any reports or information contained in it.

Principals or employees of BAMinvestor may have a position in, and may from time to time purchase or sell, securities of any company discussed in this report.